SIDEROS Phase 3 Trial of Puldysa in Duchenne Patients Completes Enrollment
News
The SIDEROS Phase 3 clinical trial, investigating if oral Puldysa (idebenone) can be added to a stable glucocorticoid regimen to more effectively slow lung function decline in boys and men with Duchenne ... Read more